The U.S. Food and Drug Administration (FDA) has cleared a noninvasive, brain-stimulating magnetic system for the management of anxiety in depression, and telepsychiatry proves successful for post-traumatic stress disorder (PTSD) and bipolar disorder — read on for more mental health news from August 2021.